Thu, Sep 18, 2014, 10:34 AM EDT - U.S. Markets close in 5 hrs 26 mins


% | $
Quotes you view appear here for quick access.

Sucampo Pharmaceuticals, Inc. (SCMP) Message Board

  • jrus2010 jrus2010 Aug 8, 2012 9:37 AM Flag

    SCMP moving towards profitability

    Was on the call last night, pretty surprised at the potential here.

    Net loss of only $800K for the quarter. Revs increasing from $14.4M in Q112 to $16.7M in Q212. They are on a run rate of about $64M in revs, which at a 5X multiple for companies with increasing revs, should put them at $320M market cap. They are currently trading at $171M market cap. They also have $88.6M in cash and equivalents at end of Q212.

    Major potential for PPS increase, as they have lots happening in Q3/Q412 including:
    -they just got Japan approval for Amitiza, and expect $15M milestone on first sale
    -potential UK approval for Amitiza by next month
    -FDA acceptance of their sNDA for non-cancer pain in Q3. This is the first oral product filed.
    -they just ironed out their differences with partner Takeda and fired the COO to smooth things over. I don't rule out a takeover at this point. They should be profitable in next 2 quarters.

    The issues with SCMP are a CEO who isn't the wall street type, and very little analyst coverage. This has bottomed out and will only go up from here.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.59-0.01(-0.15%)10:25 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.